AL-335
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for AL-335, covering 2017-01-23 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants [Phase 1]